Row
R
ROIVAI Stock Diagnostic Report
Roivant Sciences GAAP EPS of -$0.26 beats by $0.06, revenue of $1.44M misses by $0.9M
Roivant Sciences reported a 2nd quarter GAAP EPS that exceeded expectations, but revenue fell short of estimates, and selling, general and administrative expenses increased.
View Source Article ↗AI CATALYST SCORE50 / 100Score computed by Sentinel V12
REFERENCE PRICENot measuredReference entry price at analysis time